Skip to main content
. 2022 Feb 23;12(2):e054091. doi: 10.1136/bmjopen-2021-054091

Figure 3.

Figure 3

Descriptive results (continued) of in-person assessments at baseline (T0), mid-chemotherapy (T1), after completion of chemotherapy (T2), and 1 year follow-up (T3) by group assignment. EORTC, European Organisation for Research and Treatment of Cancer; MFI, Multidimensional Fatigue Inventory; NRS, Nutritional Risk Score.